256161 amendment 1 funds increase

The State of Utah Department of Health and Human Services is pursuing a non-competitive contract amendment (256161 Amendment 1) to increase funding for the Cobas Infinity POC Solution License and Support Agreement with Roche Diagnostics Corporation. This procurement represents a technological upgrade to existing laboratory equipment and services, with the contract structured as an agency contract with an estimated total value of $852,500.00. The amendment increases the original contract value from $20,000.00 to a combined total of $872,500.00, representing a 436.3% increase justified by the need for technological upgrades and additional funding requirements. The License and Support Agreement encompasses software licensing and comprehensive support services for the Infinity diagnostic system, with pricing and financial terms outlined in an associated Roche Products Supply Agreement that may include allowances, surcharges, or discounts under a bundled transaction arrangement. The contract requires full compliance with 42 CFR Part 1001.952(h) regulations regarding discount reporting and mandates that Utah State Hospital accurately report all discounts in required Medicare/Medicaid cost reports filed with federal and state authorities. The contract becomes binding upon written acceptance by an authorized Roche Diagnostics representative in Indianapolis, Indiana, with all signature requirements requiring completion. The notice period for public challenge extends from the March 12, 2026 posting date through March 23, 2026, during which interested and qualified vendors may contest the sole source determination by submitting documentation demonstrating competing sources or comparable products.

This procurement is being pursued without engaging in a standard competitive process based on claims that transitional costs are significant, there is only one viable source, or that standard procurement would be impractical and not in the state's best interest. No specific set-aside designations for disadvantaged enterprises or restrictions limiting eligible respondents are identified in the procurement documents. Roche Diagnostics Corporation is the identified incumbent vendor and proposed sole-source awardee for this contract amendment. The procurement requires all vendors responding to this notice to certify compliance with Utah Code 63G-27 et seq., specifically certifying they are not engaged in economic boycotts or boycotts of the State of Israel and agreeing to maintain such compliance throughout the contract term. The contract does not specify a defined term or renewal options, though funding may be supplemented if the legislature provides additional appropriations for the identified scope of work. All supporting documentation, including the License and Support Agreement, Business Confidentiality Claims, and detailed justification for the non-competitive award, have been submitted to the Division of Purchasing for evaluation and determination of whether the sole source or other exemption criteria are satisfied before final contract award authorization.